Novel Topical Stick for C. albicans

Infections caused by Candida albicans are a major health concern, especially among individuals with weakened immune systems. Conventional antifungal treatments are often hindered by challenges such as low patient adherence, unwanted systemic side effects, and suboptimal drug retention. This research focuses on the formulation of a novel topical antifungal stick designed for targeted and sustained delivery of the active ingredient. The formulation combines both natural and synthetic excipients, optimizing drug release, stability, and ease of application. A potent antifungal agent effective against Candida albicans is incorporated, along with skin penetration enhancers and moisturizing agents to improve comfort and enhance drug absorption. Various physicochemical properties, including melting point, spreadability , drug content uniformity, and in vitro release rates, were analyzed to assess the formulation's effectiveness and stability. Antifungal activity was further confirmed through agar diffusion assays. The results indicate that the antifungal stick exhibits desirable physicochemical properties, sustained drug release, and strong antifungal activity. This innovative formulation offers a promising alternative to traditional topical antifungal treatments, improving patient compliance, convenience, and therapeutic outcomes.